Stocks
Fate Therapeutics (FATE) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -39.9% | -44.3% | -30.4% | -52.7% | -43.7% | -49.2% | ||
| Changes by years, y/y, % | +2pp | -4pp | +14pp | -22pp | +9pp | +1.0% | |||
Fate Therapeutics. ROE, %
Fate Therapeutics. ROE, changes, pp
Fate Therapeutics (FATE) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -38.6% | -41.0% | -44.6% | -44.3% | -49.2% | -49.2% | |
| Changes by years, y/y, % | +15pp | +12pp | -1pp | -1pp | -11pp | |||
| Changes by quarters, q/q, % | +5pp | -2pp | -4pp | +0pp | -5pp | |||
